首页> 外文期刊>Cadernos de Saúde Pública >Avalia??o da exposi??o ocupacional ao chumbo: proposta de uma estratégia de monitoramento para preven??o dos efeitos clínicos e subclínicos
【24h】

Avalia??o da exposi??o ocupacional ao chumbo: proposta de uma estratégia de monitoramento para preven??o dos efeitos clínicos e subclínicos

机译:职业展览的评价导致:预防临床和亚临床效应监测策略的提案

获取原文
       

摘要

In developing countries, lead-acid battery factories are one of the heaviest consumers of lead. Due to lead's toxicological properties and prevalent working conditions in such factories, workers are subject to high exposure and health risk. This study discusses results obtained by lead exposure assessment of workers from a Rio de Janeiro battery factory, in light of Brazilian legislation and recent scientific data. Evaluation methods used were environmental (personal air sampling) and biological (determination of lead in blood, Pb-B) monitoring, showing a high personal exposure both in air (>0.1 mg/m3) and blood (55% of Pb-B >25μg/dl). These results confirmed the inefficiency of current control measures, with a possible 46% of workers presenting a Pb-B range of 25-60 μg/dl in risk areas. Recent data suggest that Pb-B levels above 25 μg/dl are related to subclinical alterations in human body that should be investigated during clinical examination. Finally, we propose a strategy based on environmental and biological monitoring to prevent both clinical and subclinical effects.
机译:在发展中国家,铅酸蓄电池厂是最重的铅消费者之一。由于铅的毒理学特性和普遍的工作条件在这些工厂中,工人受到高暴露和健康风险。本研究讨论了通过巴西立法和最近的科学数据从里约热内卢电池厂的工人铅暴露评估获得的结果。使用的评估方法是环境(个人空气采样)和生物学(血液,PB-B中铅的测定)监测,在空气(> 0.1mg / m 3)和血液中显示出高的个人暴露(55%的PB-B> 25μg/ dl)。这些结果证实了当前控制措施的效率低,可能的46%的工人在风险区域呈现为25-60μg/ dl的PB-B系列。最近的数据表明,25μg/ dL以上的PB-B水平与应在临床检查期间应研究的人体亚临床改变有关。最后,我们提出了一种基于环境和生物学监测的策略,以防止临床和亚临床效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号